| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Application of Multicategory Exposure Marginal Structural Models to Investigate the Association between Long-Acting Beta-Agonists and Prescribing of Oral Corticosteroids for Asthma Exacerbations in the Clinical Practice Research Datalink
|
Ali, Ayad K.
|
|
2015
|
18 |
2 |
p. 260-270
11 p.
|
artikel
|
| 2 |
A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part I: Descriptive Characteristics
|
Janssens, Astrid
|
|
2015
|
18 |
2 |
p. 315-333
19 p.
|
artikel
|
| 3 |
A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part II: Evaluation of Psychometric Performance of English-Language Versions in a General Population
|
Janssens, Astrid
|
|
2015
|
18 |
2 |
p. 334-345
12 p.
|
artikel
|
| 4 |
A Unified Framework for Classification of Methods for Benefit-Risk Assessment
|
Najafzadeh, Mehdi
|
|
2015
|
18 |
2 |
p. 250-259
10 p.
|
artikel
|
| 5 |
Clinical Trials Provide Essential Evidence, but Rarely Offer a Vehicle for Cost-Effectiveness Analysis
|
Sculpher, Mark
|
|
2015
|
18 |
2 |
p. 141-142
2 p.
|
artikel
|
| 6 |
Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Following First-Line Therapy in Patients with Follicular Lymphoma
|
Chen, Qiushi
|
|
2015
|
18 |
2 |
p. 189-197
9 p.
|
artikel
|
| 7 |
Copyright/Subscription
|
|
|
2015
|
18 |
2 |
p. iv-
1 p.
|
artikel
|
| 8 |
Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report
|
Ramsey, Scott D.
|
|
2015
|
18 |
2 |
p. 161-172
12 p.
|
artikel
|
| 9 |
Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence
|
Zhong, Yue
|
|
2015
|
18 |
2 |
p. 308-314
7 p.
|
artikel
|
| 10 |
Critical Appraisal of Network Meta-Analyses Evaluating the Efficacy and Safety of New Oral Anticoagulants in Atrial Fibrillation Stroke Prevention Trials
|
Cope, Shannon
|
|
2015
|
18 |
2 |
p. 234-249
16 p.
|
artikel
|
| 11 |
Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”: A Novel Measure for Cost-Containment of Drug Expenditure
|
Garattini, Livio
|
|
2015
|
18 |
2 |
p. 352-
1 p.
|
artikel
|
| 12 |
Dynamic Simulation in Health Care Comes of Age
|
Roberts, Mark S.
|
|
2015
|
18 |
2 |
p. 143-144
2 p.
|
artikel
|
| 13 |
Economic Evaluation of Tocilizumab Monotherapy Compared to Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis
|
Carlson, Josh J.
|
|
2015
|
18 |
2 |
p. 173-179
7 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2015
|
18 |
2 |
p. IFC-
1 p.
|
artikel
|
| 15 |
Effect of Adherence and Insulin Delivery System on Clinical and Economic Outcomes among Patients with Type 2 Diabetes Initiating Insulin Treatment
|
Ayyagari, Rajeev
|
|
2015
|
18 |
2 |
p. 198-205
8 p.
|
artikel
|
| 16 |
Erratum
|
|
|
2015
|
18 |
2 |
p. 353-
1 p.
|
artikel
|
| 17 |
Erratum
|
|
|
2015
|
18 |
2 |
p. 353-
1 p.
|
artikel
|
| 18 |
Erratum
|
|
|
2015
|
18 |
2 |
p. 353-
1 p.
|
artikel
|
| 19 |
Fairness versus Efficiency of Vaccine Allocation Strategies
|
Yi, Ming
|
|
2015
|
18 |
2 |
p. 278-283
6 p.
|
artikel
|
| 20 |
Implications of the Minimal Clinically Important Difference for Health-Related Quality-of-Life Outcomes: A Comparison of Sample Size Requirements for an Incontinence Treatment Trial
|
Halme, Alex S.
|
|
2015
|
18 |
2 |
p. 292-298
7 p.
|
artikel
|
| 21 |
Instructions for Authors
|
|
|
2015
|
18 |
2 |
p. I-II
nvt p.
|
artikel
|
| 22 |
Learning and Satisficing: An Analysis of Sequence Effects in Health Valuation
|
Craig, Benjamin M.
|
|
2015
|
18 |
2 |
p. 217-223
7 p.
|
artikel
|
| 23 |
Mapping the Clinical Chronic Obstructive Pulmonary Disease Questionnaire onto Generic Preference-Based EQ-5D Values
|
Boland, Melinde R.S.
|
|
2015
|
18 |
2 |
p. 299-307
9 p.
|
artikel
|
| 24 |
Merging Regulatory and Reimbursement Needs in Clinical Trials
|
Cook, John R.
|
|
2015
|
18 |
2 |
p. 145-146
2 p.
|
artikel
|
| 25 |
Need for Multicriteria Evaluation of Generic Drug Policies
|
Kaló, Zoltán
|
|
2015
|
18 |
2 |
p. 346-351
6 p.
|
artikel
|
| 26 |
Potential Application of Machine Learning in Health Outcomes Research and Some Statistical Cautions
|
Crown, William H.
|
|
2015
|
18 |
2 |
p. 137-140
4 p.
|
artikel
|
| 27 |
Predictors of Self-Reported Adherence to Antihypertensive Medicines: A Multinational, Cross-Sectional Survey
|
Morrison, Valerie L.
|
|
2015
|
18 |
2 |
p. 206-216
11 p.
|
artikel
|
| 28 |
Public Preferences for Prioritizing Preventive and Curative Health Care Interventions: A Discrete Choice Experiment
|
Luyten, Jeroen
|
|
2015
|
18 |
2 |
p. 224-233
10 p.
|
artikel
|
| 29 |
Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research—Part 2: Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force
|
Marshall, Deborah A.
|
|
2015
|
18 |
2 |
p. 147-160
14 p.
|
artikel
|
| 30 |
Strengthening Tuberculosis Control Overseas: Who Benefits?
|
Nguyen, Hoa Thi Minh
|
|
2015
|
18 |
2 |
p. 180-188
9 p.
|
artikel
|
| 31 |
Table of Contents
|
|
|
2015
|
18 |
2 |
p. i-iii
nvt p.
|
artikel
|
| 32 |
The Changing Face of the Cost-Utility Literature, 1990–2012
|
Neumann, Peter J.
|
|
2015
|
18 |
2 |
p. 271-277
7 p.
|
artikel
|
| 33 |
Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006–2013
|
Charokopou, Mata
|
|
2015
|
18 |
2 |
p. 284-291
8 p.
|
artikel
|
Tijdschrift beschrijving